Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit A11 (NDUFA11)

Target
NDUFA11
Molecular classification
Enzyme (mitochondrial complex I accessory subunit), Mitochondrial electron transport chain component, Respiratory chain accessory protein
01

Overview

NADH:ubiquinone oxidoreductase subunit A11 (NDUFA11) is an accessory subunit of mitochondrial complex I (NADH dehydrogenase), a large multi-subunit enzyme complex responsible for the transfer of electrons from NADH to ubiquinone in the mitochondrial electron transport chain. NDUFA11 is encoded in the nuclear genome and is believed to play a role in the assembly, stability, and regulation of complex I rather than catalyzing electron transfer directly. Mutations in NDUFA11 are associated with mitochondrial complex I deficiency, manifesting as a spectrum of often severe neurological and metabolic disorders. While NDUFA11 itself is not a commonly exploited drug target, proper function is essential for cellular ATP production and oxidative phosphorylation.

Other names
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11CI-B14.7B14.7Complex I-B14.7NADH-ubiquinone oxidoreductase subunit B14.7complex I B14.7 subunitMC1DN14
02

Mechanism of action

Drugs that inhibit mitochondrial complex I (e.g., rotenone) impair electron transport and energy production, but NDUFA11 is not a direct drug target

03

Biological functions

Assembly, stability, and regulation of mitochondrial complex ISupports ATP generation via oxidative phosphorylationContributes to electron transfer from NADH to ubiquinone
04

Disease associations

Mitochondrial complex I deficiencyNeurodegenerative disease (via mitochondrial dysfunction)Cardiovascular disease (via energy metabolism dysregulation)
05

Safety considerations

Dysfunction or inhibition of mitochondrial complex I leads to cellular energy failure, risk of lactic acidosis, neurotoxicity, and myopathies
06

Biomarkers

Mitochondrial complex I activity (global marker)Genetic variants of NDUFA11 for inherited mitochondrial disorders

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit A11 (NDUFA11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A11 (NDUFA11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call